CN102125129A - 一种保健茶 - Google Patents
一种保健茶 Download PDFInfo
- Publication number
- CN102125129A CN102125129A CN2011100593107A CN201110059310A CN102125129A CN 102125129 A CN102125129 A CN 102125129A CN 2011100593107 A CN2011100593107 A CN 2011100593107A CN 201110059310 A CN201110059310 A CN 201110059310A CN 102125129 A CN102125129 A CN 102125129A
- Authority
- CN
- China
- Prior art keywords
- health care
- care tea
- tea
- kilograms
- blood sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000036541 health Effects 0.000 title claims abstract description 24
- 241001122767 Theaceae Species 0.000 title description 25
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 12
- 240000000249 Morus alba Species 0.000 claims abstract description 12
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 12
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 12
- 244000269722 Thea sinensis Species 0.000 claims abstract 13
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract 3
- 244000234609 Portulaca oleracea Species 0.000 claims abstract 3
- 240000002948 Ophiopogon intermedius Species 0.000 claims description 12
- 241000522254 Cassia Species 0.000 claims description 11
- 239000008280 blood Substances 0.000 abstract description 26
- 210000004369 blood Anatomy 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 13
- 239000003814 drug Substances 0.000 abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 6
- 230000006870 function Effects 0.000 abstract description 6
- 206010020772 Hypertension Diseases 0.000 abstract description 4
- 235000012000 cholesterol Nutrition 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000009835 boiling Methods 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 240000008027 Akebia quinata Species 0.000 abstract 1
- 235000007756 Akebia quinata Nutrition 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 229920003266 Leaf® Polymers 0.000 description 19
- 241001065361 Gynostemma Species 0.000 description 9
- 241000219304 Portulacaceae Species 0.000 description 9
- 230000003203 everyday effect Effects 0.000 description 9
- 235000012054 meals Nutrition 0.000 description 8
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000002394 glycogenic effect Effects 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Abstract
本发明一种保健茶，属于中药保健技术领域，特别是以麦冬为主要原料制备的保健茶。提出一种具有调节血脂、降低血糖的保健茶，该茶具有对“三高”人群较好的预防和辅助治疗的作用。本发明保健茶由麦冬、肉桂、桑叶、老茶叶、绞股蓝和马齿苋组成。本发明选用的原料为药典上有明确作用的药物，也是药膳同源的植物，利用中药的综合作用调节血糖，血脂和胆固醇的指标，使其趋于正常值，无化学添加剂，对人体无毒无害。本发明原料粉碎后混合分装为小剂量的小包，饮用时只需要用开水浸即可，方便快捷。
Description
技术领域
本发明属于中药保健技术领域，特别是以麦冬为主要原料制备的保健茶。
背景内容
随着生活水平的提高和生活节奏的改变，被称为“富贵病”的高血压、高血糖和高血脂即“三高症”已经成为常见病，特别是50岁以上中老年人发病更高。“三高症”已成为威胁人类健康与生命的主要的危险因素，是健康的三大杀手。“三高症”的患者，一般都是通过服药治疗或调节。本发明的保健茶有辅助治疗的作用，并且也有预防的作用。
发明内容
本发明要解决的技术问题是：提出一种具有调节血脂、降低血糖的保健茶，该茶具有对“三高”人群较好的预防和辅助治疗的作用。
本发明解决技术问题的技术方案是：保健茶由麦冬、肉桂、桑叶、老茶叶、绞股蓝和马齿苋组成，其要点是，原料按以下重量百分比制备保健茶
麦冬38-42％ 肉桂8-12％ 桑叶24-28％
老茶叶8-12％ 绞股蓝2-6％ 马齿苋8-12％。
本发明的有益效果是：
本发明保健茶中麦冬、肉桂、桑叶、老茶叶、绞股蓝和马齿苋，具有如下作用：肉桂：主要成份为桂油。有改善血糖，血脂和胆固醇的作用。可使血糖代谢水平提高20倍。40天可降30％左右，同时刺激机体分泌胰岛素。
桑叶：含云香甙、懈皮素、甾醇溶血素、酚类、延胡索酸、天门冬氨酸。谷胱甘肽高达140-400毫斯/百克.且有阻碍糖质分解酶的活性。
老茶叶：本发明采用生长一年以上的老叶片，其茶多糖是不足一年生长期茶叶的五到六倍，其有效药用成分有①生物碱、茶碱、主要作用兴奋中枢神经，提高工作效率，利尿、松弛平滑肌、降胆固醇和防止动脉粥样硬化的作用；②儿茶素，是一种活性物质。能增强血管壁弹性，增强血管渗透作用；③茶多糖，能增强肌体非特异性免疫功能，防辐射损伤，降低血糖；④蛋白质与氨基酸，其精华是多种肽类化合物，能调节人体的各种生理机能；⑤维生素与矿物质，对清除自由基，延缓衰老有明显作用。
麦冬，含多种甾体皂甙，主治热痛伤沣、口渴心烦，咽干肺燥。萎缩性胃炎。主要能促进胰岛细胞功能恢复，增加肝糖元和降血糖的作用。
绞股蓝，含三大成份，皂甙类，黄酮类和多糖类。有调节人体生理机能，增强免疫功能，抵消糖皮激素副作用，还有降血糖，清除自由基等功能。
马齿苋，含蛋白质，不饱和脂肪酸，核黄素，抗坏血酸，矿物质等。具有抗菌消炎，清热消毒，凉血止血等功能。又因含去甲肾上腺素，能促进胰岛素分泌，调节人体血糖代谢，降低血糖浓度，保持血糖恒定的作用。
本发明所选取的原料含有多种皂甙、生物碱、氨基酸、多糖、不饱和脂肪酸、黄酮类等丰富的营养成份。
本发明保健茶中所含的主要营养成份含量见下表1
表1
本发明保健茶有如下优点：
1、本发明选用的原料为药典上有明确作用的药物，也是药膳同源的植物，利用中药的综合作用调节血糖，血脂和胆固醇的指标，使其趋于正常值，无化学添加剂，对人体无毒无害。
2、本发明将原料粉碎后混合分装为小剂量的小包，饮用时只需要用开水浸即可，方便快捷。
3、本发明即可与有“三高”症状的患者服用的药同时饮用，开始一月内与治疗“三高”的药物同时服用，每天早晚用80℃冲服2-4袋，以饭后为佳。也可以在症状基本正常后，单独饮用。没有“三高”症状的人群饮用，可以起到预防的作用。
本发明经对如下几例“三高”症患者的服用观察，都有明显的调节、降低“三高”和作用：
1、唐X，于2009年患糖尿病，空腹血糖为18，体重减轻明显，瘦6公斤，每天注射2次胰岛素，40毫克/天。从2010年6月开始服用本品后，餐后血糖调节到11-13。
2、汪X，科技工作者，患高血压长伴头痛，从6月开始服用本品后，调节作用明显，头痛症状消失。
3、徐X，年龄72岁，男，于2009年检验“三高”的指标为血压为96/180mmHg，空腹血糖为24，餐后35。从2010年6月开始服用发明的保健茶后，每天5克量2小包，分为两次泡饮，服用三个月后，检验的指标为血压为80-90/140-150mmHg，血糖为空腹6-4，餐后11-1，10月初停打胰岛素。
4、周X，年龄55岁，女，于2009年检验“三高”的指标为血压为110/190mmHg，血糖为餐前10.5，餐后16.7，血脂为6.26mmol/L(200mg/dl)。从2010年9月开始服用发明的保健茶后，每天每包5克量2小包，分为两次泡饮，服用三个月后，检验的指标为血压为90/140mmHg，血糖为餐前6.76，餐后10.1，血脂为5.35mmol/L(200mg/dl)。
具体实施方式
下面结合实施例对本发明做进一步详细说明。
实施例1
麦冬38千克、肉桂10千克、桑叶22千克、老茶叶12千克、绞股蓝6千克、马齿苋12千克。
将上述原料粉碎后混合，分装为0.5克的小袋。开始一月内与治疗“三高”的药物同时服用，每天早晚用80℃冲服2-4袋，以饭后为佳。在症状基本正常后，一次一袋，每日1-2次。
实施例2
麦冬38千克、肉桂10千克、桑叶22千克、老茶叶12千克、绞股蓝6千克、马齿苋12千克。
将上述原料粉碎后混合，分装为0.5克的小袋。每天用开水冲服1-2袋。
实施例3
麦冬38千克、肉桂10千克、桑叶22千克、老茶叶12千克、绞股蓝6千克、马齿苋12千克。
将上述原料粉碎后混合，分装为0.5克的小袋。每天用开水冲服1-2袋。
实施例4
麦冬38千克、肉桂10千克、桑叶22千克、老茶叶12千克、绞股蓝6千克、马齿苋12千克。
将上述原料粉碎后混合，分装为0.5克的小袋。每天用开水冲服1-2袋。
实施例5
麦冬38千克、肉桂10千克、桑叶22千克、老茶叶12千克、绞股蓝6千克、马齿苋12千克。
将上述原料粉碎后混合，分装为0.5克的小袋。每天用开水冲服1-2袋。
本发明所说的“老茶叶”为生长一年以上的老叶片。
本发明所说的“三高”是指高血压、高血糖(糖尿病)和高血脂。
Claims (1)
1.一种保健茶，由麦冬、肉桂、桑叶、老茶叶、绞股蓝和马齿苋组成，其特征是，原料按以下重量百分比制备保健茶
麦冬38-42％ 肉桂8-12％ 桑叶24-28％
老茶叶8-12％ 绞股蓝2-6％ 马齿苋8-12％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110059310 CN102125129B (zh) | 2011-03-14 | 2011-03-14 | 一种保健茶 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110059310 CN102125129B (zh) | 2011-03-14 | 2011-03-14 | 一种保健茶 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102125129A true CN102125129A (zh) | 2011-07-20 |
| CN102125129B CN102125129B (zh) | 2013-05-15 |
Family
ID=44263586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110059310 Active CN102125129B (zh) | 2011-03-14 | 2011-03-14 | 一种保健茶 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102125129B (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102920807A (zh) * | 2012-11-26 | 2013-02-13 | 龚定军 | 一种降血压的药茶 |
| CN102972560A (zh) * | 2012-12-24 | 2013-03-20 | 福州快乐园艺有限公司 | 一种新鲜老茶叶饮料 |
| CN103960395A (zh) * | 2014-05-23 | 2014-08-06 | 安徽荃力电子科技有限公司 | 一种麦冬保健茶 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1092605A (zh) * | 1993-12-17 | 1994-09-28 | 田加奎 | 多功能天然保健茶 |
| CN101564190A (zh) * | 2008-04-23 | 2009-10-28 | 刘泳宏 | 一种天然养肝明目茶及加工方法 |
| CN101683161A (zh) * | 2008-09-26 | 2010-03-31 | 刘泳宏 | 一种天然清热祛火茶饮料及制作方法 |
-
2011
- 2011-03-14 CN CN 201110059310 patent/CN102125129B/zh active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1092605A (zh) * | 1993-12-17 | 1994-09-28 | 田加奎 | 多功能天然保健茶 |
| CN101564190A (zh) * | 2008-04-23 | 2009-10-28 | 刘泳宏 | 一种天然养肝明目茶及加工方法 |
| CN101683161A (zh) * | 2008-09-26 | 2010-03-31 | 刘泳宏 | 一种天然清热祛火茶饮料及制作方法 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102920807A (zh) * | 2012-11-26 | 2013-02-13 | 龚定军 | 一种降血压的药茶 |
| CN102972560A (zh) * | 2012-12-24 | 2013-03-20 | 福州快乐园艺有限公司 | 一种新鲜老茶叶饮料 |
| CN103960395A (zh) * | 2014-05-23 | 2014-08-06 | 安徽荃力电子科技有限公司 | 一种麦冬保健茶 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102125129B (zh) | 2013-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101138374B (zh) | 一种杜仲茶颗粒及其制备方法 | |
| CN105126067B (zh) | 一种降尿酸的组合物及其用途 | |
| CN103181434B (zh) | 一种舒心保健茶及其制备方法 | |
| KR101387695B1 (ko) | 갈근, 둥굴레 줄기 및 오디의 엑기스를 주성분으로 하는 항당뇨 조성물 | |
| CN102125129B (zh) | 一种保健茶 | |
| CN101711798A (zh) | 一种用于降血脂、降血糖的制剂 | |
| CN105029553A (zh) | 一种果汁蛋钙中药保健饮料及其制备方法 | |
| CN103300197A (zh) | 一种助眠茶及其制作方法 | |
| CN103005439B (zh) | 一种苦瓜复方降脂口服液及其制备方法 | |
| CN109453317A (zh) | 一种用于滋补强壮的蒙药及其制备工艺 | |
| CN107737280A (zh) | 用于治疗糖尿病的中药组合物及其制备方法和应用 | |
| CN115120684B (zh) | 一种治疗糖尿病的中药组方及其加工方法 | |
| CN102326813A (zh) | 白花丹参功能饮料及其制备方法 | |
| CN107233491A (zh) | 一种提高精力抗疲劳的玛咖组合物 | |
| CN102784230A (zh) | 一种治疗营养性贫血的药物组合物制剂 | |
| RU2197868C2 (ru) | Биологически активная пищевая добавка (варианты) | |
| CN104413195A (zh) | 一种凤眼莲降糖茶及其制备方法 | |
| CN101611868A (zh) | 一种降血压、血脂、血糖的凉茶及其制备方法 | |
| CN101559081A (zh) | 蚌肉提取物在制备治疗和预防糖尿病的药物中的应用 | |
| CN104474103A (zh) | 一种天然植物降糖剂及其制备方法 | |
| CN103550333A (zh) | 一种开胃降血压组合物 | |
| CN108991198A (zh) | 一组调经暖宫防掉发的保健食品及药品的配方及其制备方法 | |
| CN103689298B (zh) | 用于治疗僵猪的饲料及其制备方法 | |
| CN104223062B (zh) | 一种降压降糖的地骨皮保健口服液及其制备方法 | |
| CN101116504B (zh) | 降血脂的保健品及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Health-care tea and its preparing process Effective date of registration: 20160718 Granted publication date: 20130515 Pledgee: Shaanxi Pingli rural commercial bank Limited by Share Ltd Pledgor: Pingli County Shencao Park Tea Industry Co., Ltd. Registration number: 2016610000029 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 725509 A Group of Zhongyuan Village, Chang'an Town, Pingli County, Ankang City, Shaanxi Province Patentee after: Pingli Shencaoyuan Tea Industry Co., Ltd. Address before: 725509 A Group of Zhongyuan Village, Chang'an Town, Pingli County, Ankang City, Shaanxi Province Patentee before: Pingli County Shencao Park Tea Industry Co., Ltd. |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190823 Granted publication date: 20130515 Pledgee: Shaanxi Pingli rural commercial bank Limited by Share Ltd Pledgor: Pingli County Shencao Park Tea Industry Co., Ltd. Registration number: 2016610000029 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Health-care tea and its preparing process Effective date of registration: 20190826 Granted publication date: 20130515 Pledgee: Shaanxi Pingli rural commercial bank Limited by Share Ltd Pledgor: Pingli Shencaoyuan Tea Industry Co., Ltd. Registration number: Y2019980000061 |